CRNXCrinetics Pharmaceuticals, Inc.

CIK 0001658247 · no recent filings · 0 insider transactions

All Form 4 filings on EDGAR ↗

Buy volume

0 buy transactions

Sell volume

0 sell transactions

Net flow

+$0

Net buying

Total flow

0 priced transactions

Disclosure radarcross-source convergence

Divergent1/5 sources

Recent disclosures · timeline

Form 14421h ago
JEFF KNIGHT ↗
Proposed sale of 47,420 sh ($1.83M) · discretionary
Form 14421h ago
ROGERIO VIVALDI COELHO ↗
Proposed sale of 6,000 sh ($232.1K) · discretionary

Price · CRNX

Live chart by TradingView

Live chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.

Proposed sales · Form 144

selling intent · live SEC data

2 notices$2.07M proposed to sell0/2 under a 10b5-1 plan

Filed	Filer	Shares	Est. value	Approx. sale	Source of shares	Plan
21h ago	JEFF KNIGHT Officer	47,420	$1.83M	Jul 02, 2026	Exercise of Stock Options	Discretionary
21h ago	ROGERIO VIVALDI COELHO Director	6,000	$232.1K	Jul 02, 2026	Restricted Stock Units	Discretionary

Recent insider transactions

No insider transactions recorded for CRNX.

Convergence is a transparent heuristic sum of attributable disclosure factors — not a price target or recommendation. 8-K events are shown as context; Form 144 planned sales count against bullish conviction. Not financial advice.